Bruce L Levine

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 29

Top Venues

Nature medicine

Blood advances

Nature

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Julie K Jadlowsky, Ju-Fang Chang, David H Spencer, John M Warrington, Bruce L Levine, Carl H June, Joseph A Fraietta, Nathan Singh
Regulatory Considerations for Genome-Edited T-cell Therapies. Cancer immunology research (2024)
Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivanna M Van Deerlin, Jennifer J D Morrissette, Gabriel C Caponetti, Luca Paruzzo, Jaryse C Harris, Elise A Chong, Sandra P Susanibar-Adaniya, Jakub Svoboda, Sunita D Nasta, Ositadimma H Ugwuanyi, Daniel J Landsburg, Eugenio Fardella, Adam J Waxman, Emeline R Chong, Vrutti Patel, Raymone Pajarillo, Irina Kulikovskaya, David B Lieberman, Adam David Cohen, Bruce L Levine, Edward A Stadtmauer, Noelle V Frey, Dan T Vogl, Elizabeth O Hexner, Stefan K Barta, David L Porter, Alfred L Garfall, Stephen J Schuster, Carl H June, Marco Ruella
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy. Nature medicine 30 (4) (2024)
Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivanna M Van Deerlin, Jennifer J D Morrissette, Gabriel C Caponetti, Luca Paruzzo, Jaryse C Harris, Elise A Chong, Sandra P Susanibar-Adaniya, Jakub Svoboda, Sunita D Nasta, Ositadimma H Ugwuanyi, Daniel J Landsburg, Eugenio Fardella, Adam J Waxman, Emeline R Chong, Vrutti Patel, Raymone Pajarillo, Irina Kulikovskaya, David B Lieberman, Adam David Cohen, Bruce L Levine, Edward A Stadtmauer, Noelle V Frey, Dan T Vogl, Elizabeth O Hexner, Stefan K Barta, David L Porter, Alfred L Garfall, Stephen J Schuster, Carl H June, Marco Ruella
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy. Nature medicine 30 (4) (2024)
Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivanna M Van Deerlin, Jennifer J D Morrissette, Gabriel C Caponetti, Luca Paruzzo, Jaryse C Harris, Elise A Chong, Sandra P Susanibar-Adaniya, Jakub Svoboda, Sunita D Nasta, Ositadimma H Ugwuanyi, Daniel J Landsburg, Eugenio Fardella, Adam J Waxman, Emeline R Chong, Vrutti Patel, Raymone Pajarillo, Irina Kulikovskaya, David B Lieberman, Adam David Cohen, Bruce L Levine, Edward A Stadtmauer, Noelle V Frey, Dan T Vogl, Elizabeth O Hexner, Stefan K Barta, David L Porter, Alfred L Garfall, Stephen J Schuster, Carl H June, Marco Ruella
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy. Nature medicine (2024)
Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivanna M Van Deerlin, Jennifer J D Morrissette, Gabriel C Caponetti, Luca Paruzzo, Jaryse C Harris, Elise A Chong, Sandra P Susanibar-Adaniya, Jakub Svoboda, Sunita D Nasta, Ositadimma H Ugwuanyi, Daniel J Landsburg, Eugenio Fardella, Adam J Waxman, Emeline R Chong, Vrutti Patel, Raymone Pajarillo, Irina Kulikovskaya, David B Lieberman, Adam David Cohen, Bruce L Levine, Edward A Stadtmauer, Noelle V Frey, Dan T Vogl, Elizabeth O Hexner, Stefan K Barta, David L Porter, Alfred L Garfall, Stephen J Schuster, Carl H June, Marco Ruella
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy. Nature medicine 30 (4) (2024)
Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivanna M Van Deerlin, Jennifer J D Morrissette, Gabriel C Caponetti, Luca Paruzzo, Jaryse C Harris, Elise A Chong, Sandra P Susanibar-Adaniya, Jakub Svoboda, Sunita D Nasta, Ositadimma H Ugwuanyi, Daniel J Landsburg, Eugenio Fardella, Adam J Waxman, Emeline R Chong, Vrutti Patel, Raymone Pajarillo, Irina Kulikovskaya, David B Lieberman, Adam David Cohen, Bruce L Levine, Edward A Stadtmauer, Noelle V Frey, Dan T Vogl, Elizabeth O Hexner, Stefan K Barta, David L Porter, Alfred L Garfall, Stephen J Schuster, Carl H June, Marco Ruella
T-cell Lymphoma and Secondary Primary Malignancy Risk After Commercial CAR T-cell Therapy. Nature medicine (2024)
Julie K Jadlowsky, Ju-Fang Chang, David H Spencer, John M Warrington, Bruce L Levine, Carl H June, Joseph A Fraietta, Nathan Singh
Regulatory Considerations for Genome-Edited T-cell Therapies. Cancer immunology research 12 (9) (2024)
Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivanna M Van Deerlin, Jennifer J D Morrissette, Gabriel C Caponetti, Luca Paruzzo, Jaryse C Harris, Elise A Chong, Sandra P Susanibar-Adaniya, Jakub Svoboda, Sunita D Nasta, Ositadimma H Ugwuanyi, Daniel J Landsburg, Eugenio Fardella, Adam J Waxman, Emeline R Chong, Vrutti Patel, Raymone Pajarillo, Irina Kulikovskaya, David B Lieberman, Adam David Cohen, Bruce L Levine, Edward A Stadtmauer, Noelle V Frey, Dan T Vogl, Elizabeth O Hexner, Stefan K Barta, David L Porter, Alfred L Garfall, Stephen J Schuster, Carl H June, Marco Ruella
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy. Nature medicine 30 (4) (2024)
Bruce L Levine, Marcelo C Pasquini, John E Connolly, David L Porter, Michael P Gustafson, Jaap-Jan Boelens, Edwin M Horwitz, Stephan A Grupp, Marcela V Maus, Frederick L Locke, Fabio Ciceri, Annalisa Ruggeri, John A Snowden, Helen E Heslop, Crystal L Mackall, Carl H June, Anna M Sureda, Miguel-Ángel Perales
Unanswered questions following reports of secondary malignancies after CAR-T cell therapy. Nature medicine 30 (2) (2024)
Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivanna M Van Deerlin, Jennifer J D Morrissette, Gabriel C Caponetti, Luca Paruzzo, Jaryse C Harris, Elise A Chong, Sandra P Susanibar-Adaniya, Jakub Svoboda, Sunita D Nasta, Ositadimma H Ugwuanyi, Daniel J Landsburg, Eugenio Fardella, Adam J Waxman, Emeline R Chong, Vrutti Patel, Raymone Pajarillo, Irina Kulikovskaya, David B Lieberman, Adam David Cohen, Bruce L Levine, Edward A Stadtmauer, Noelle V Frey, Dan T Vogl, Elizabeth O Hexner, Stefan K Barta, David L Porter, Alfred L Garfall, Stephen J Schuster, Carl H June, Marco Ruella
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy. Nature medicine (2024)
Bruce L Levine, Marcelo C Pasquini, John E Connolly, David L Porter, Michael P Gustafson, Jaap-Jan Boelens, Edwin M Horwitz, Stephan A Grupp, Marcela V Maus, Frederick L Locke, Fabio Ciceri, Annalisa Ruggeri, John A Snowden, Helen E Heslop, Crystal L Mackall, Carl H June, Anna M Sureda, Miguel-Ángel Perales
Unanswered questions following reports of secondary malignancies after CAR-T cell therapy. Nature medicine (2024)
Bruce L Levine, Marcelo C Pasquini, John E Connolly, David L Porter, Michael P Gustafson, Jaap-Jan Boelens, Edwin M Horwitz, Stephan A Grupp, Marcela V Maus, Frederick L Locke, Fabio Ciceri, Annalisa Ruggeri, John A Snowden, Helen E Heslop, Crystal L Mackall, Carl H June, Anna M Sureda, Miguel-Ángel Perales
Unanswered questions following reports of secondary malignancies after CAR-T cell therapy. Nature medicine 30 (2) (2024)
Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivanna M Van Deerlin, Jennifer J D Morrissette, Gabriel C Caponetti, Luca Paruzzo, Jaryse C Harris, Elise A Chong, Sandra P Susanibar-Adaniya, Jakub Svoboda, Sunita D Nasta, Ositadimma H Ugwuanyi, Daniel J Landsburg, Eugenio Fardella, Adam J Waxman, Emeline R Chong, Vrutti Patel, Raymone Pajarillo, Irina Kulikovskaya, David B Lieberman, Adam David Cohen, Bruce L Levine, Edward A Stadtmauer, Noelle V Frey, Dan T Vogl, Elizabeth O Hexner, Stefan K Barta, David L Porter, Alfred L Garfall, Stephen J Schuster, Carl H June, Marco Ruella
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy. Nature medicine (2024)
Sara Bobisse, Valentina Bianchi, Janos L Tanyi, Apostolos Sarivalasis, Edoardo Missiaglia, Rémy Pétremand, Fabrizio Benedetti, Drew A Torigian, Raphaël Genolet, David Barras, Alexandra Michel, Spyridon A Mastroyannis, Emese Zsiros, Denarda Dangaj Laniti, Zoi Tsourti, Brian J Stevenson, Christian Iseli, Bruce L Levine, Daniel E Speiser, David Gfeller, Michal Bassani-Sternberg, Daniel J Powell, Carl H June, Urania Dafni, Lana Elias Kandalaft, Alexandre Harari, Sergio A Quezada
A phase 1 trial of adoptive transfer of vaccine-primed autologous circulating T cells in ovarian cancer. Nature cancer (2023)
Caroline Diorio, Rawan Shraim, Regina M Myers, Edward M Behrens, Scott W Canna, Hamid Bassiri, Richard Aplenc, Chakkapong Burudpakdee, Fang Chen, Amanda M DiNofia, Saar Gill, Vanessa Gonzalez, Michele P Lambert, Allison Barz Leahy, Bruce L Levine, Robert B Lindell, Shannon L Maude, Jan Joseph Melenhorst, Haley M Newman, Jessica Perazzelli, Alix E Seif, Simon F Lacey, Carl H June, David M Barrett, Stephan A Grupp, David Trent Teachey
Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (17) (2022)
Saar Gill, Vanessa Vides, Noelle V Frey, Elizabeth O Hexner, Susan Metzger, Megan O'Brien, Wei-Ting Hwang, Jennifer L Brogdon, Megan M Davis, Joseph A Fraietta, Avery L Gaymon, Whitney L Gladney, Simon F Lacey, Anne Lamontagne, Anthony R Mato, Marcela V Maus, Jan Joseph Melenhorst, Edward Pequignot, Marco Ruella, Maksim Shestov, John C Byrd, Stephen J Schuster, Donald L Siegel, Bruce L Levine, Carl H June, David L Porter
Anti-CD19 CAR T cells in combination with ibrutinib for the treatment of chronic lymphocytic leukemia. Blood advances 6 (21) (2022)
Jan Joseph Melenhorst, Gregory M Chen, Meng Wang, David L Porter, Changya Chen, McKensie A Collins, Peng Gao, Shovik Bandyopadhyay, Hongxing Sun, Ziran Zhao, Stefan Lundh, Iulian Pruteanu-Malinici, Christopher L Nobles, Sayantan Maji, Noelle V Frey, Saar I Gill, Alison W Loren, Lifeng Tian, Irina Kulikovskaya, Minnal Gupta, David E Ambrose, Megan M Davis, Joseph A Fraietta, Jennifer L Brogdon, Regina M Young, Anne Chew, Bruce L Levine, Donald L Siegel, Cécile Alanio, E John Wherry, Frederic D Bushman, Simon F Lacey, Kai Tan, Carl H June
Decade-long leukaemia remissions with persistence of CD4 + CAR T cells. Nature 602 (7897) (2022)
Jan Joseph Melenhorst, Gregory M Chen, Meng Wang, David L Porter, Changya Chen, McKensie A Collins, Peng Gao, Shovik Bandyopadhyay, Hongxing Sun, Ziran Zhao, Stefan Lundh, Iulian Pruteanu-Malinici, Christopher L Nobles, Sayantan Maji, Noelle V Frey, Saar I Gill, Alison W Loren, Lifeng Tian, Irina Kulikovskaya, Minnal Gupta, David E Ambrose, Megan M Davis, Joseph A Fraietta, Jennifer L Brogdon, Regina M Young, Anne Chew, Bruce L Levine, Donald L Siegel, Cécile Alanio, E John Wherry, Frederic D Bushman, Simon F Lacey, Kai Tan, Carl H June
Author Correction: Decade-long leukaemia remissions with persistence of CD4 + CAR T cells. Nature (2022)
Regina M Myers, Yimei Li, Allison Barz Leahy, David M Barrett, David Trent Teachey, Colleen Callahan, Christina C Fasano, Susan R Rheingold, Amanda M DiNofia, Lisa Wray, Richard Aplenc, Diane Baniewicz, Hongyan Liu, Pamela A Shaw, Edward Pequignot, Kelly D Getz, Jennifer L Brogdon, Andrew D Fesnak, Donald L Siegel, Megan M Davis, Chelsie Bartoszek, Simon F Lacey, Elizabeth O Hexner, Anne Chew, Gerald B Wertheim, Bruce L Levine, Carl H June, Stephan A Grupp, Shannon L Maude
Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (27) (2021)
Carrie Ho, Marco Ruella, Bruce L Levine, Jakub Svoboda
Adoptive T-cell therapy for Hodgkin lymphoma. Blood advances 5 (20) (2021)
Muzaffar H Qazilbash, Neeraj Y Saini, Cha Soung-Chul, Zhe Wang, Edward Stadtmauer, Veerabhadran Baladandayuthapani, Heather Lin, Beryl Tross, Medhavi Honhar, Sheetal S Rao, Kunhwa Kim, Michael Popescu, Szymon Jakub Szymura, Tiantian Zhang, Aaron J Anderson, Qaiser Bashir, Elizabeth J Shpall, Robert Z Orlowski, Bruce L Levine, Naseem Kerr, Alfred L Garfall, Adam David Cohen, Dan T Vogl, Karen Dengel, Carl H June, Richard E Champlin, Larry W Kwak
A Randomized Phase II Trial of Idiotype Vaccination and Adoptive Autologous T-Cell Transfer in Multiple Myeloma patients. Blood (2021)
Shwetha H Manjunath, Adam David Cohen, Simon F Lacey, Megan M Davis, Alfred L Garfall, J Joseph Melenhorst, Russell Maxwell, W Tristram Arscott, Amit Maity, Joshua A Jones, John P Plastaras, Edward A Stadtmauer, Bruce L Levine, Carl H June, Michael C Milone, Ima Paydar
The Safety of Bridging Radiation with Anti-BCMA CAR T-Cell Therapy for Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (23) (2021)
Edward A Stadtmauer, Joseph A Fraietta, Megan M Davis, Adam David Cohen, Kristy L Weber, Eric Lancaster, Patricia A Mangan, Irina Kulikovskaya, Minnal Gupta, Fang Chen, Lifeng Tian, Vanessa E Gonzalez, Jun Xu, In-Young Jung, J Joseph Melenhorst, Gabriela Plesa, Joanne Shea, Tina Matlawski, Amanda Cervini, Avery L Gaymon, Stephanie Desjardins, Anne Lamontagne, January Salas-Mckee, Andrew D Fesnak, Donald L Siegel, Bruce L Levine, Julie K Jadlowsky, Regina M Young, Anne Chew, Wei-Ting Hwang, Elizabeth O Hexner, Beatriz M Carreno, Christopher L Nobles, Frederic D Bushman, Kevin R Parker, Yanyan Qi, Ansuman T Satpathy, Howard Y Chang, Yangbing Zhao, Simon F Lacey, Carl H June
CRISPR-engineered T cells in patients with refractory cancer. Science (New York, N.Y.) 367 (6481) (2020)
Alfred L Garfall, Ehren K Dancy, Adam David Cohen, Wei-Ting Hwang, Joseph A Fraietta, Megan M Davis, Bruce L Levine, Don L Siegel, Edward A Stadtmauer, Dan T Vogl, Adam Waxman, Aaron P Rapoport, Michael C Milone, Carl H June, J Joseph Melenhorst
T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myeloma. Blood advances 3 (19) (2020)
Janos L Tanyi, Sara Bobisse, Eran Ophir, Sandra Tuyaerts, Annalisa Roberti, Raphaël Genolet, Petra Baumgartner, Brian J Stevenson, Christian Iseli, Denarda Dangaj, Brian J Czerniecki, Aikaterini Semilietof, Julien Racle, Alexandra Michel, Ioannis Xenarios, Cheryl Chiang, Dimitri S Monos, Drew A Torigian, Harvey L Nisenbaum, Olivier Michielin, Carl H June, Bruce L Levine, Daniel J Powell, David Gfeller, Rosemarie Mick, Urania Dafni, Vincent Zoete, Alexandre Harari, Sergio A Quezada, Lana Elias Kandalaft
Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer. Science translational medicine 10 (436) (2019)
Marco Ruella, Jun Xu, David M Barrett, Joseph A Fraietta, Tyler J Reich, David E Ambrose, Michael Klichinsky, Olga Shestova, Prachi R Patel, Irina Kulikovskaya, Farzana Nazimuddin, Vijay G Bhoj, Elena J Orlando, Terry J Fry, Hans Bitter, Shannon L Maude, Bruce L Levine, Christopher L Nobles, Frederic D Bushman, Regina M Young, John Scholler, Saar I Gill, Carl H June, Stephan A Grupp, Simon F Lacey, J Joseph Melenhorst
Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell. Nature medicine 24 (10) (2018)
Joseph A Fraietta, Simon F Lacey, Elena J Orlando, Iulian Pruteanu-Malinici, Mercy Gohil, Stefan Lundh, Alina C Boesteanu, Yan Wang, Roddy S O'Connor, Wei-Ting Hwang, Edward Pequignot, David E Ambrose, Changfeng Zhang, Nicholas Wilcox, Felipe Bedoya, Corin Dorfmeier, Fang Chen, Lifeng Tian, Harit Parakandi, Minnal Gupta, Regina M Young, F Bradley Johnson, Irina Kulikovskaya, Li Liu, Jun Xu, Sadik H Kassim, Megan M Davis, Bruce L Levine, Noelle V Frey, Donald L Siegel, Alexander C Huang, E John Wherry, Hans Bitter, Jennifer L Brogdon, David L Porter, Carl H June, J Joseph Melenhorst
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia. Nature medicine 24 (5) (2018)
Donald M O'Rourke, Mac Lean P Nasrallah, Arati S Desai, Jan Joseph Melenhorst, Keith G Mansfield, Jennifer J D Morrissette, Maria Martinez-Lage, Steven Brem, Eileen Maloney, Angela Shen, Randi Isaacs, Suyash Mohan, Gabriela Plesa, Simon F Lacey, Jean-Marc Navenot, Zhaohui Zheng, Bruce L Levine, Hideho Okada, Carl H June, Jennifer L Brogdon, Marcela V Maus
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma. Science translational medicine 9 (399) (2018)
Joseph A Fraietta, Kyle A Beckwith, Prachi R Patel, Marco Ruella, Zhaohui Zheng, David M Barrett, Simon F Lacey, Jan Joseph Melenhorst, Shannon E McGettigan, Danielle R Cook, Changfeng Zhang, Jun Xu, Priscilla Do, Jessica Hulitt, Sagar B Kudchodkar, Alexandria P Cogdill, Saar I Gill, David L Porter, Jennifer A Woyach, Meixiao Long, Amy J Johnson, Kami Maddocks, Natarajan Muthusamy, Bruce L Levine, Carl H June, John C Byrd, Marcela V Maus
Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia. Blood 127 (9) (2016)

Bruce L Levine.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Bruce L Levine